Author

Ravi Iyer

Ravi Iyer covers the business of biotech for Dark Biotechnology: funding rounds, hiring, partnerships and market moves, figures labeled company-claimed where the company is the only source.

Articles by Ravi Iyer

An engineer adjusting a bioreactor control panel in a facility of glass and brushed steel, teal instrument glow on gloved hands.

Biotech News

Why Biotech Manufacturing Capacity Announcements Are Reshaping U.S. Drug Supply

Ravi Iyer

A researcher adjusts a bioreactor control panel, gloved hands on steel, cool teal indicator light across the lab.

Biotech News

Halozyme Licenses ENHANZE Technology to Incyte for Subcutaneous INCA033989 in MPNs

Ravi Iyer

A researcher in safety glasses reviewing trial safety monitoring charts at a cool-lit laboratory bench.

Biotech News

FDA's Expedited IND Comment Window Nears Close After Gene Therapy Holds

Ravi Iyer

A scientist adjusts a bioreactor control panel in a facility of glass and brushed steel, cool teal-white light, no logos or readouts.

Biotech News

Gilead and Lakefront Complete $1.675 Billion Ouro Medicines Acquisition

Ravi Iyer

A researcher loads labeled sample racks into a benchtop centrifuge, glass and steel surfaces catching cool teal lab light, no logos visible.

Biotech News

FDA Accepts Vertex's Povetacicept BLA in IgA Nephropathy With November Decision

Ravi Iyer

A clinical operations lead reviewing site monitoring binders across a brushed-steel desk under cool white laboratory lighting.

Biotech

The CRO Industry Explained: How Contract Research Organizations Run Modern Clinical Trials

Ravi Iyer